Release issued 27th November 2002

FOR IMMEDIATE RELEASE 11/27/02

Contact: Tara Niebergall +1 210-476-8158 tara.niebergall@dptlabs.com

(San Antonio, TX) — John Feik, President and COO of DPT Laboratories, Ltd. has announced that its parent company, DFB Pharmaceuticals and its affiliates DPT (San Antonio, Tx. & Lakewood, N.J.) and Healthpoint, Ltd. (Ft. Worth, Tx.) have been granted a license for a patented topical skin protectant technology from the United States Army Medical Research & Materiel Command.

The skin protectant technology is currently approved by the Food and Drug Administration (FDA) as a prescription pharmaceutical for military use only that, when used in conjunction with appropriate protective clothing, protects soldiers from skin exposure to chemical warfare agents. The cream contains polytetraflouroethylene resins, compounds that are similar to the substances that coat non-stick cooking utensils.

This technology represents the first FDA-approved prescription skin protectant drug designed to help the military guard against dangers from chemical warfare agents.

Although approved by the FDA for military use, DFB's Healthpoint affiliate will be pursuing discussions with regulatory agencies to determine necessary requirements for the existing military product to be labeled for use by first responders and consumers. Beyond that, Healthpoint will immediately begin to determine requirements to obtain approvals for the use of this technology as it relates to reducing the reoccurrence of contact dermatitis associated with exposure of skin to a variety of irritants including allergens such as poison ivy, oak and sumac, solvents, and bodily fluids.

The agreement was signed in September. "This licensing agreement is part of our continuing effort to expand and enhance our $14 million contact dermatitis franchise worldwide," stated Mr. Feik. "Such unique, patented prescription products complement DFB's expertise in semi-solid and liquid research, development, and manufacturing. The product also reaffirms our proficiency in licensing, sales, and marketing of novel skin and soft tissue specialty pharmaceutical products and technologies."

DFB Pharmaceuticals, through its branded marketing organizations, contract partners and affiliates, provides technology-driven products, outsourcing services, and licensing opportunities that significantly benefit the skin and soft tissue to the healthcare industry worldwide. DFB has two affiliates, HEALTHTPOINT and DPT Laboratories. Website is www.dfb.com.

HEALTHPOINT, with over 225 employees, is a market leader in innovative tissue management, dermatology, and infection prevention. HEALTHPOINT was founded in1992 and has established a national presence in the research, development, and marketing of branded pharmaceuticals, over the counter drugs, and medical devices for wound treatment, skin protection, dermatology and surgical applications. An aggressive research and development effort has brought HEALTHPOINT's unique technologies to the market, setting the pace for its highly trained national field sales organization of direct sales representatives. HEALTHPOINT has headquarters in Fort Worth, Texas, with additional offices in Canada. Visit HEALTHPOINT on the web at www.healthpoint.com.

With a heritage dating back to 1938, DFB affiliate DPT is an independent, privately owned company that strives to build long-term partnerships. DPT specializes in the full service development, manufacturing, packaging and worldwide distribution of semisolid and liquid, Rx, OTC and biotech products. DPT's full range of packaging services includes solid, semisolid and liquid dosage forms. Customers include most of the top fortune 500 pharmaceutical and consumer product companies, as well as biotechnology and start-up companies. DPT, based in San Antonio, Texas with additional facilities in Lakewood, New Jersey, has 1500 employees. For more information, visit DPT's website at www.dptlabs.com.

(19th March 2004) Paul Johnson Named President, DPT Laboratories, Ltd.

(17th October 2003) DFB's Braham Shroot, B.Sc., Ph.D, honored with American Skin Association's Lifetime Achievement Award

(5th December 2002) Duncan Aust, Ph.D. Joins DPT Research and Development

(10th September 2002) Sie-Ta (Robert) Han, Ph.D. Joins DPT Research and Development

(27th August 2002) DPT Laboratories, Ltd. Implements Baan ERP in newly acquired facility